NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis

CompletedN/A

Sponsor: Pfizer

Conditions: Ulcerative Colitis

Interventions: Tofacitinib

Countries: France

This is an observational prospective study with two years of follow-up, designed to evaluate the effectiveness of tofacitinib in patients with moderate to severe ulcerative colitis in French clinical practice

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients of 18 years old or above
* Patients with confirmed diagnosis of moderate to severe ulcerative colitis
* Patients for whom gastroenterologist decides to initiate treatment with tofacitinib as per the French SmPC
* Patients informed about the study procedures and receiving an information letter signed by the investigator

Exclusion Criteria:

* Patients who have already received tofacitinib treatment before baseline
* Patients that fulfill any of the contrindications according to the latest version of the SmPC

Locations (38)

Amiens, France
Amiens, France
Besançon, France
Caen, France
Cahors, France
Caluire-et-Cuire, France
Chambray-lès-Tours, France
Clermont-Ferrand, France
Clichy, France
Créteil, France
Dunkirk, France
La Tronche, France
Le Kremlin-Bicêtre, France
Le Mans, France
Le Puy-en-Velay, France
Lille, France
Lyon, France
Montfermeil, France
Montpellier, France
Montpellier, France
Nantes, France
Nantes, France
Nice, France
Nîmes, France
Paris, France
Paris, France
Paris, France
Paris, France
Pessac, France
Pierre-Bénite, France
+ 8 more on CT.gov